Later onset of vitiligo in patients with melanoma who initiated anti-PD-1 therapy was associated with a lower 3-year mortality rate.

Immunocore will present five-year overall survival data for KIMMTRAK during oral presentation at the 2026 AACR meeting ...

Uveal melanoma is a rare cancer with limited treatment options, and approximately 90% of patients who develop metastatic disease have liver involvement. In a small randomized trial, 55% of patients ...

Immunocore reports fourth quarter and full year 2025 financial results and provides a business update KIMMTRAK (tebentafusp-tebn) Q4 net sales of $104.5 million and $400.0 million for full year 2025; ...

Credit: Getty Images Known as the “great masquerader,” amelanotic melanoma may resemble a variety of benign lesions, thereby increasing diagnostic complexity. Depending on disease stage and risk ...

A team at UT Southwestern Medical Center this week became the first in Texas and neighboring states to successfully perform a novel procedure to deliver whole-liver chemotherapy to treat metastatic ...

Uveal melanoma primarily affects the choroid and is diagnosed using tools like ultrasound, fluorescein angiography, and biopsy. Treatment focuses on preserving vision and includes plaque brachytherapy ...

Risk factors are things that raise your chances of getting a disease. For each person, there’s a mix of lifestyle, biological and genetic factors that play a part in melanoma risk. Exposure to ...

A new study demonstrates the effectiveness of a widely-used eye injection to manage the previously untreatable rare condition, hypotony, in a project by clinical researchers at UCL and Moorfields Eye ...

The Hepzato Kit is the first FDA-approved liver-directed therapy for unresectable metastatic uveal melanoma, showing consistent efficacy across diverse patient subgroups. Patients with lower tumor ...

(NewsNation) — Tanning beds cause melanoma-linked DNA damage across nearly the entire surface of the skin, a new study found. The precise biological process behind the increased risk of melanoma ...